Search research articles
Contact Us
Filters
Showing results (91-100 of 274) with videos related to
Page
of 28
Sort By:
Cancer Research
|
August 1, 1983
Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers
D O Adams, W J Johnson, P A Marino, et al.
Mayo Clinic Proceedings
|
June 1, 1971
Segmental demyelination secondary to axonal degeneration in uremic neuropathy
P J Dyck, W J Johnson, E H Lambert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1983
Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development
W J Johnson, P A Marino, R D Schreiber, et al.
Experientia
|
March 15, 1976
Effect of fructose administration on serum urate levels in the uricase inhibited rat
B Stavric, W J Johnson, S Clayman, et al.
Archives of Internal Medicine
|
March 1, 1970
Hemodialysis. Comparison of treatment in the medical center, community hospital, and home
W J Johnson, D S Hathaway, C F Anderson, et al.
Mayo Clinic Proceedings
|
November 1, 1984
Hospitalization in dialysis patients
D M Carlson, D A Duncan, J M Naessens, et al.
Journal of Lipid Research
|
March 1, 1995
Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol
E P Kilsdonk, D W Morel, W J Johnson, et al.
Kidney International. Supplement
|
October 1, 1974
Metabolic problems in diabetic patients undergoing renal transplantation
P J Palumbo, J E Woods, W J Johnson, et al.
Archives of Internal Medicine
|
February 1, 1973
Causes of death after renal transplantation
H R Tapia, K E Holley, J E Woods, et al.
Mayo Clinic Proceedings
|
January 1, 1973
Survival of patients with end-stage renal disease
W J Johnson, H O O'Kane, J E Woods, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 274) with videos related to
Sort By:
Page
of 28
Cancer Research
|
August 1, 1983
Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers
D O Adams, W J Johnson, P A Marino, et al.
Mayo Clinic Proceedings
|
June 1, 1971
Segmental demyelination secondary to axonal degeneration in uremic neuropathy
P J Dyck, W J Johnson, E H Lambert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1983
Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development
W J Johnson, P A Marino, R D Schreiber, et al.
Experientia
|
March 15, 1976
Effect of fructose administration on serum urate levels in the uricase inhibited rat
B Stavric, W J Johnson, S Clayman, et al.
Archives of Internal Medicine
|
March 1, 1970
Hemodialysis. Comparison of treatment in the medical center, community hospital, and home
W J Johnson, D S Hathaway, C F Anderson, et al.
Mayo Clinic Proceedings
|
November 1, 1984
Hospitalization in dialysis patients
D M Carlson, D A Duncan, J M Naessens, et al.
Journal of Lipid Research
|
March 1, 1995
Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol
E P Kilsdonk, D W Morel, W J Johnson, et al.
Kidney International. Supplement
|
October 1, 1974
Metabolic problems in diabetic patients undergoing renal transplantation
P J Palumbo, J E Woods, W J Johnson, et al.
Archives of Internal Medicine
|
February 1, 1973
Causes of death after renal transplantation
H R Tapia, K E Holley, J E Woods, et al.
Mayo Clinic Proceedings
|
January 1, 1973
Survival of patients with end-stage renal disease
W J Johnson, H O O'Kane, J E Woods, et al.
Page
of 28